Skip to main content
Back to feed
MarketsSingle-sourceLow
2.1

Double Bond Pharma reports Q2 2026 operating loss of 0.6 million SEK

Double Bond Pharma reported an operating loss of 0.6 million SEK for Q2 2026, compared to 0.4 million SEK in the same period last year. The company is currently engaged in discussions with potential partners to address its financial position.

Dagens Industriabout 8 hours agoSECredibility 28%View source

Score Breakdown

Mosaic Score2.1
Confidence0.9
Significance0.1
Source credibility0.3

Intelligence Tags

#earnings#biotech#sweden#financials

Locations

Stockholm

Entities

country
Source

Related signals

8 found